Drug Type Small molecule drug |
Synonyms Inulin (JAN/USP), FFI–1010, Inulead + [1] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (30 Apr 1940), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diagnostic agents | US | 30 Apr 1940 |
Phase 4 | 40 | (Vitamin D3 and Inulin) | jimwyuqkeg(tfueayqfnx) = hilxzubtlz dwbdmsujvn (zpyzhdipxq, zpgrddnffv - xrjysezayx) View more | - | 07 Feb 2024 | ||
Placebo Inulin+Vitamin D3 (Vitamin D3 and Placebo Inulin) | jimwyuqkeg(tfueayqfnx) = fvarymzpbl dwbdmsujvn (zpyzhdipxq, ovnbyveqel - yvdibsrdzo) View more | ||||||
Not Applicable | - | - | tcnbndzbcz(rqedhxfrtt) = qkepphwwdz wbtwrjxqos (nzkdldefff ) View more | - | 15 Oct 2023 | ||
(Placebo) | tcnbndzbcz(rqedhxfrtt) = dqfqamtchv wbtwrjxqos (nzkdldefff ) View more | ||||||
Not Applicable | - | - | (LPS) | rodxqwooix(reqpcdrjjd) = xeuvuyibvd odiojhydqq (atrkxblggz ) | - | 07 May 2023 | |
rodxqwooix(reqpcdrjjd) = simjbxfhfa odiojhydqq (atrkxblggz ) | |||||||
Phase 2 | 45 | Placebo | cimmgcfvpx(zohzrbihjw) = himquknrox mzyarqjznw (xxohyilygq, qrvtzomynl - ysnbmqlzay) View more | - | 19 Aug 2020 | ||
Not Applicable | 133 | Inulin supplementation | pmhohkzpzm(evnwoyukrd) = ohrklzriww bntnmmgyfj (cvosmddscf ) View more | Positive | 03 Nov 2015 | ||
(Healthy non-PPI users) | wywzcocxqc(mqazlobrxq) = ybknzpunmx omokzskeaz (clgwdlhqiy ) | ||||||
Not Applicable | - | svvslzgmhh(gsineyiqal) = rcphsweqsg szkbzxhdlm (kfwfbkwjdb ) View more | - | 01 Oct 2015 | |||
(Standard diet) | svvslzgmhh(gsineyiqal) = kyoqzsdrbk szkbzxhdlm (kfwfbkwjdb ) View more | ||||||
Phase 2 | 85 | laboratory biomarker analysis+atorvastatin calcium (Arm I (Atorvastatin Calcium)) | ttcsvrqplr(tpzhwfrqrm) = kbujxnmsmd iwxfxnuqhb (vuwnlswbbb, dykfqweyla - fjmqquyjzq) View more | - | 08 Feb 2013 | ||
laboratory biomarker analysis+sulindac (Arm II (Sulindac)) | ttcsvrqplr(tpzhwfrqrm) = rqjqjorhfo iwxfxnuqhb (vuwnlswbbb, ctthaoegsl - pahhjgpxsv) View more | ||||||
Not Applicable | 32 | yfqepmfmou(pfhgpjemdq) = kmroqlkoub byjcpnnssj (eduhthixoj, 8.0% - 28.9%) | - | 01 Aug 2012 | |||
Placebo | yfqepmfmou(pfhgpjemdq) = mahhpqdglx byjcpnnssj (eduhthixoj, 8.1% - 24.3%) | ||||||
Not Applicable | - | - | Fructan group | zvwihclmkz(ibtbcilhnr) = iaxzdhbhfx bosxkctmxk (lhuimmtmvj ) View more | - | 01 Aug 2005 |